Related Experiment Video
Updated: May 2, 2026

Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
ABCC4 is required for cell proliferation and tumorigenesis in non-small cell lung cancer
Xiaoting Zhao1, Yinan Guo1, Wentao Yue1
1Department of Cellular and Molecular Biology, Beijing TB and Thoracic Tumor Research Institute/Beijing Chest Hospital, Capital Medical University, Beijing, People's Republic of China.
Background:
Multidrug resistance protein 4 (MRP4), also known as ATP-cassette binding protein 4 (ABCC4), is a member of the MRP/ABCC subfamily of ATP-binding cassette transporters, which are capable of pumping a wide variety of drugs out of the cell. However, little is known about the function of ABCC4 in the proliferation of lung cancer cells.
Methods:
ABCC4 mRNA and protein levels in lung cancer cell lines were measured by real-time polymerase chain reaction and Western blot, respectively. A lentivirus-mediated RNA interference technique was used to inhibit ABCC4 mRNA expression in A549 and 801D cells. The function of ABCC4 in cell growth was investigated by MTS and colony formation assays. The role of ABCC4 in cell cycle progression was evaluated by flow cytometry and Western blot analysis. ABCC4 mRNA levels in 30 pairs of tumors and corresponding matched adjacent normal tissues from non-small cell lung cancer patients were detected by real-time polymerase chain reaction.
Results:
ABCC4 was highly expressed in lung cancer cell lines. ABCC4 expression was markedly downregulated in A549 and 801D cells using the RNA interference technique. Suppression of ABCC4 expression inhibited cell growth. The percentage of cells in G1 phase was increased when ABCC4 expression was suppressed. Phosphorylation of retinoblastoma protein was weakened, originating in the downregulation of ABCC4. ABCC4 mRNA was highly expressed in lung cancer tissue and lung cancer cell lines.
Conclusion:
ABCC4 may play an important role in the control of A549 and 801D cell growth. ABCC4 is a potential target for lung cancer therapy.
Insights
Multidrug resistance protein 4 (MRP4/ABCC4) is highly expressed in lung cancer cells and drives proliferation. Inhibiting ABCC4 suppresses lung cancer cell growth and may offer a new therapeutic target.
Area of Science:
- Molecular biology
- Cancer research
- Cell biology
Background:
- Multidrug resistance protein 4 (MRP4), also known as ATP-cassette binding protein 4 (ABCC4), is an ATP-binding cassette transporter involved in drug efflux.
- The specific role of ABCC4 in lung cancer cell proliferation remains largely uncharacterized.
Purpose of the Study:
- To investigate the expression and function of ABCC4 in lung cancer cell proliferation.
- To determine if ABCC4 could serve as a therapeutic target for lung cancer.
Main Methods:
- Quantitative real-time PCR and Western blotting were used to assess ABCC4 mRNA and protein levels in lung cancer cell lines and patient tissues.
- Lentivirus-mediated RNA interference was employed to suppress ABCC4 expression in A549 and 801D cells.
- Cell proliferation was evaluated using MTS and colony formation assays, while cell cycle progression was analyzed by flow cytometry and Western blotting.
Main Results:
- ABCC4 was found to be highly expressed in lung cancer cell lines and patient tumor tissues.
- Suppression of ABCC4 expression using RNA interference led to inhibited cell growth in A549 and 801D cells.
- Downregulation of ABCC4 resulted in an increased percentage of cells in the G1 phase and weakened retinoblastoma protein phosphorylation, indicating cell cycle arrest.
Conclusions:
- ABCC4 plays a significant role in regulating the proliferation of lung cancer cells.
- ABCC4 represents a promising molecular target for the development of novel lung cancer therapies.
Related Concept Videos
Abnormal Proliferation
Inhibition of Cdk Activity
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

